HBT
ABBV icon

Hills Bank & Trust’s AbbVie ABBV Stock Holding History

Hills Bank & Trust’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.46M Buy
6,730
+589
+10% +$131K 0.07% 123
2025
Q4 		$1.4M Buy
6,141
+789
+15% +$180K 0.08% 126
2025
Q3 		$1.24M Sell
5,352
-235
-4% -$47.9K 0.07% 138
2025
Q2 		$1.04M Sell
5,587
-146
-3% -$27.1K 0.07% 147
2025
Q1 		$1.2M Sell
5,733
-150
-3% -$29.2K 0.08% 129
2024
Q4 		$1.05M Sell
5,883
-163
-3% -$30K 0.08% 134
2024
Q3 		$1.19M Buy
6,046
+168
+3% +$31.4K 0.09% 128
2024
Q2 		$1.01M Buy
5,878
+31
+0.5% +$5.13K 0.08% 138
2024
Q1 		$1.06M Buy
5,847
+917
+19% +$158K 0.09% 131
2023
Q4 		$764K Hold
4,930
– – 0.07% 139
2023
Q3 		$735K Sell
4,930
-15
-0.3% -$2.2K 0.09% 130
2023
Q2 		$666K Sell
4,945
-192
-4% -$28.2K 0.09% 125
2023
Q1 		$819K Sell
5,137
-121
-2% -$18.5K 0.11% 112
2022
Q4 		$850K Buy
5,258
+614
+13% +$94.1K 0.13% 105
2022
Q3 		$623K Sell
4,644
-766
-14% -$110K 0.09% 117
2022
Q2 		$829K Sell
5,410
-1,118
-17% -$171K 0.13% 106
2022
Q1 		$1.06M Sell
6,528
-202
-3% -$29.3K 0.15% 102
2021
Q4 		$911K Sell
6,730
-622
-8% -$73.5K 0.13% 109
2021
Q3 		$793K Buy
7,352
+590
+9% +$67.4K 0.12% 112
2021
Q2 		$762K Buy
6,762
+14
+0.2% +$1.58K 0.12% 116
2021
Q1 		$730K Buy
6,748
+345
+5% +$36.9K 0.12% 115
2020
Q4 		$686K Sell
6,403
-211
-3% -$20.3K 0.12% 114
2020
Q3 		$579K Sell
6,614
-1,702
-20% -$160K 0.11% 118
2020
Q2 		$817K Buy
8,316
+2,185
+36% +$192K 0.17% 97
2020
Q1 		$467K Hold
6,131
– – 0.14% 97
2019
Q4 		$543K Hold
6,131
– – 0.13% 100
2019
Q3 		$464K Hold
6,131
– – 0.12% 103
2019
Q2 		$446K Sell
6,131
-70
-1% -$5.5K 0.12% 108
2019
Q1 		$500K Buy
6,201
+1,563
+34% +$128K 0.13% 103
2018
Q4 		$427K Buy
4,638
+193
+4% +$17K 0.13% 102
2018
Q3 		$420K Sell
4,445
-21
-0.5% -$1.99K 0.11% 106
2018
Q2 		$414K Hold
4,466
– – 0.12% 98
2018
Q1 		$422K Buy
4,466
+642
+17% +$70.5K 0.13% 97
2017
Q4 		$370K Sell
3,824
-200
-5% -$18.8K 0.11% 104
2017
Q3 		$358K Sell
4,024
-100
-2% -$7.61K 0.11% 101
2017
Q2 		$299K Hold
4,124
– – 0.1% 112
2017
Q1 		$269K Sell
4,124
-130
-3% -$8.17K 0.09% 113
2016
Q4 		$266K Buy
4,254
+25
+0.6% +$1.53K 0.09% 114
2016
Q3 		$267K Sell
4,229
-25
-0.6% -$1.62K 0.1% 114
2016
Q2 		$264K Buy
4,254
+400
+10% +$24.4K 0.1% 109
2016
Q1 		$220K Buy
3,854
+150
+4% +$8.36K 0.08% 114
2015
Q4 		$219K Hold
3,704
– – 0.08% 104
2015
Q3 		$202K Hold
3,704
– – 0.08% 93
2015
Q2 		$248K Sell
3,704
-400
-10% -$26.1K 0.09% 78
2015
Q1 		$241K Sell
4,104
-15
-0.4% -$906 0.09% 79
2014
Q4 		$270K Hold
4,119
– – 0.11% 73
2014
Q3 		$238K Sell
4,119
-47
-1% -$2.61K 0.1% 77
2014
Q2 		$235K Sell
4,166
-183
-4% -$9.6K 0.1% 76
2014
Q1 		$223K Sell
4,349
-345
-7% -$17.4K 0.1% 76
2013
Q4 		$248K Hold
4,694
– – 0.11% 77
2013
Q3 		$210K Buy
+4,694
New +$208K 0.1% 79

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Hills Bank & Trust's ABBV Position: Q1 2026 in Review

Hills Bank & Trust increased its AbbVie (ABBV) stake by 9.6% in Q1 2026, buying an estimated $131K and bringing the position to 6,730 shares worth $1.46M. The position accounts for 0.07% of the portfolio, ranked #123.

Hills Bank & Trust first reported a position in ABBV in Q3 2013 and has held it in 51 quarters since. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Hills Bank & Trust held 6,730 shares of AbbVie worth $1.46M as of Q1 2026.
  • Hills Bank & Trust bought 589 AbbVie shares in Q1 2026, an estimated $131K.
  • AbbVie made up 0.07% of Hills Bank & Trust's portfolio in Q1 2026, its #123 holding.
  • Hills Bank & Trust first reported a position in AbbVie in Q3 2013 and has held it in 51 quarters since.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Hills Bank & Trust's 13F filing for Q1 2026, filed 1 May 2026.